Featured Speakers

Title of speech: Zinc metallochaperones: a new class of small molecule mutant p53 reactivators: Restoring binding to zinc deficient mutant p53

Darren R. Carpizo
Assistant Prof. Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
Anti-Cancer Drug Discovery & Therapy

A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: Evaluation of efficacy, safety, and patient-reported outcomes

Kosei Kimura
Osaka Medical College Hospital, Japan
Breast Cancer Research

Title of speech: Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol

Julian Kenyon
Medical Director of The Dove Clinic , UK
Clinical Oncology

Title of speech: Data Integration Innovations to Enhance Analytic Utility of Clinical Trial Content to Inform Health Disparities Research

Steven Cohen
Vice President , RTI International, USA
Clinical Oncology

Title of speech: Differential distribution and enrichment of non-coding RNAs in exosomes from Normal and Cancer-Associated Fibroblasts in colorectal cancer

Cristina Peña
Hospital Universitario Ramón y Cajal, Spain
Cancer Genetics

Title of speech: Radiation-Induced Metabolic Alteration in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications

Kshama Gupta
Mayo Clinic, USA
Radiation, Surgical and Medical oncology

Title of speech: Novel Combination of Immunotherapy and Vaccine in HPV-Associated Oropharyngeal Cancer

Erminia Massarelli
City of Hope National Medical Center, USA
Cancer Immunology and Vaccines

Title of speech: Targeting the extracellular matrix/cancer cell interface to overcome BRAF inhibition resistance in melanoma

Barbara Bedogni
University of Miami, USA
Anti-Cancer Drug Discovery & Therapy

Title of speech: 18F-Fluoro-2-Deoxy-Glucose Positron Emission-Computed Tomography in a Rare Cutaneous Form Of Rosai Dorfman Disease

Feras Chehade
Mount Lebanon Hospital, Lebanon
Cancer Screening & Diagnosis

Title of speech: Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells

Pin Ju Chueh
National Chung Hsing University, Taiwan
Anti-Cancer Drug Discovery & Therapy

Title of speech:: Anticancer effects of Combination of Biochanin A & Statins on Glioblastoma Multiforme and Pancreatic Cancer Cells

Alok Bhushan
Jefferson College of Pharmacy, USA
Anti-Cancer Drug Discovery & Therapy

Title of speech: Hormonal Pathology of the Endometrium and Endometrial Neoplasia

Liane Deligdisch
Mount Sinai Icahn School of Medicine, USA
Cancer Screening & Diagnosis

Title of speech: Real-Time Molecular Diagnosis of Sarcomas Using Water-Assisted Laser Desorption/Ionization Mass Spectrometry Technology

Yves-Marie ROBIN
Organ Specific Cancers and Effect

Title of speech: Frequency of Human Papilloma Virus infection in Oral Squamous Cell Carcinoma and its clinical significance –A retrospective study

Regional Cancer Centre, India
Clinical Oncology

Title of speech: Oral cancer Screening -15 years’ experience from India

Kunnambath Ramadas
Regional Cancer Centre, India
Cancer Screening & Diagnosis

Title of speech: Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving bortezomib-based therapy for multiple myeloma

Wuxi People’s Hospital, China
Clinical Oncology

Title of speech: Cancer Metastasis of 118 Kinds of Solid Tumors via Cytocapsular Tubes and Networks

Tingfang Yi
Cytocapsula Research Institute, USA
Cancer Cell

Title of speech: STUM-MRMI-Studies of Tumor Microenvironment by using Magnetic Resonance Molecular Imaging

RenHua Wu
Shantou University Medical College, China
Cancer Biomarkers

Copyrights © 2016-17 Innovinc Pvt Ltd All Rights Reserved